Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Recommendations for Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy

Recommendations for Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy This JAMA Clinical Guidelines Synopsis summarizes the American Society of Clinical Oncology’s 2020 guideline on the prevention and management of chemotherapy-induced peripheral neuropathy in adults. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

Recommendations for Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy

JAMA , Volume 326 (11) – Sep 21, 2021

Loading next page...
 
/lp/american-medical-association/recommendations-for-prevention-and-management-of-chemotherapy-induced-PdqnJ5hdog
Publisher
American Medical Association
Copyright
Copyright 2021 American Medical Association. All Rights Reserved.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.2021.7458
Publisher site
See Article on Publisher Site

Abstract

This JAMA Clinical Guidelines Synopsis summarizes the American Society of Clinical Oncology’s 2020 guideline on the prevention and management of chemotherapy-induced peripheral neuropathy in adults.

Journal

JAMAAmerican Medical Association

Published: Sep 21, 2021

References